The Neuro - Profile: Alain Dagher

How much do obesity and addictions overlap?

ƻ��Ժ — Wed, 30 Oct 2019 16:30:22 +0000

Food can trigger overconsumption similar to alcohol and drugs, but it is not the whole story

A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs. But obesity is also a complex condition that cannot be fully explained by the addiction model.

Gut hormone increases response to food

ƻ��Ժ — Tue, 11 Dec 2018 15:25:01 +0000

Ghrelin promotes conditioning to food-related odours

The holiday season is a hard one for anyone watching their weight. The sights and smells of food are hard to resist. One factor in this hunger response is a hormone found in the stomach that makes us more vulnerable to tasty food smells, encouraging overeating and obesity. New research on the hormone ghrelin was published on Dec. 4, 2018, led by Dr. Alain Dagher’s lab at the Montreal Neurological Institute and Hospital of ƻ��Ժ.

The link between obesity, the brain, and genetics

ƻ��Ժ — Tue, 28 Aug 2018 15:42:51 +0000

When it comes to weight gain, the problem may be mostly in our heads, and our genes

Clinicians should consider how the way we think can make us vulnerable to obesity, and how obesity is genetically intertwined with brain structure and mental performance, according to new research.

The Neuro marks Parkinson’s Awareness Month

ƻ��Ժ — Mon, 09 Apr 2018 17:59:06 +0000

April is Parkinson’s Awareness Month, a time to give special attention to a disease that affects approximately 100,000 Canadians. As a centre for both research and clinical treatment of Parkinson’s disease (PD), the Montreal Neurological Institute and Hospital (The Neuro) offers many specialized services and opportunities to participate in research to PD patients.

April is Parkinson’s Awareness Month

ƻ��Ժ — Wed, 29 Mar 2017 19:05:27 +0000

Multidisciplinary care and cutting-edge research share space at The Neuro

The Montreal Neurological Institute and Hospital (The Neuro) is recognized worldwide for its research and clinical expertise in Parkinson’s disease (PD). PD is a motor neuron disease that is generally associated with old age, but people can also develop it in their thirties and forties. Characteristic symptoms include tremor, rigidity and gait dysfunction, mood and sleep disorders, and cognitive degeneration. About 100,000 Canadians have PD.

The Neuro – A Major Force in Parkinson’s Disease Research and Treatment

ƻ��Ժ — Mon, 04 Apr 2016 20:00:13 +0000

The Neuro – A Major Force in Parkinson’s Disease Research and Treatment

New study maps the progression of Parkinson’s disease within the brain

ƻ��Ժ — Tue, 22 Sep 2015 13:28:18 +0000

Montreal Neurological Institute scientists shed light on the mechanism that could be driving the spread of Parkinson’s along neuronal highways

Scientists at the Montreal Neurological Institute and Hospital -The Neuro, at ƻ��Ժ and the ƻ��Ժ Health Centre, have made advances in understanding the process involved in the progression and spread of Parkinson’s disease (PD) within the brain.

Neuro awarded over $15 M in CIHR funding

ƻ��Ժ — Tue, 28 Jul 2015 20:10:33 +0000

Researchers get inaugural Foundation grants for high-impact, long-term programs

Researchers from the Montreal Neurological Institute and Hospital, ƻ��Ժ have been awarded over $15 million in grants in the latest round of funding by the Canadian Institutes of Health Research (CIHR). The grants are part of over $600 million in national funding, announced July 28 by Minister of Health Rona Ambrose.

April - Parkinson’s Disease Awareness Month

ƻ��Ժ — Thu, 02 Apr 2015 13:43:31 +0000

The Montreal Neurological Institute and Hospital - The Neuro, ƻ��Ժ and the ƻ��Ժ Health Centre, is at the forefront of Parkinson’s research and clinical care. Parkinson’s patients are seen at The Neuro’s Movement Disorders Clinic and the Montreal General Hospital. Approximately 100,000 Canadians have Parkinson’s disease.

The Neuro to introduce experimental drug treatment